106 related articles for article (PubMed ID: 7981776)
1. Rewarding properties of non-competitive and competitive NMDA antagonists as measured by place preference conditioning in rats.
Papp M; Moryl E
Pol J Pharmacol; 1994; 46(1-2):79-81. PubMed ID: 7981776
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of agents acting at various sites of the NMDA receptor complex in a place preference conditioning model.
Papp M; Moryl E; Maccecchini ML
Eur J Pharmacol; 1996 Dec; 317(2-3):191-6. PubMed ID: 8997600
[TBL] [Abstract][Full Text] [Related]
3. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
Zajaczkowski W; Czyrak A; Wedzony K
Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
[TBL] [Abstract][Full Text] [Related]
4. Competitive and non-competitive NMDA receptor antagonists induce c-Fos expression in the rat anterior, cingulate cortex.
Wedzony K; Czyrak A
J Physiol Pharmacol; 1996 Sep; 47(3):525-33. PubMed ID: 8877908
[TBL] [Abstract][Full Text] [Related]
5. NMDA receptor antagonists impair motor performance in immature rats.
Mikulecká A; Mares P
Psychopharmacology (Berl); 2002 Aug; 162(4):364-72. PubMed ID: 12172689
[TBL] [Abstract][Full Text] [Related]
6. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
Massieu L; Thedinga KH; McVey M; Fagg GE
Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
[TBL] [Abstract][Full Text] [Related]
7. The competitive NMDA antagonists CGP 43487 and APV potentiate dopaminergic function.
Dall'Olio R; Rimondini R; Gandolfi O
Psychopharmacology (Berl); 1995 Apr; 118(3):310-5. PubMed ID: 7617824
[TBL] [Abstract][Full Text] [Related]
8. The competitive NMDA receptor antagonist CGP 40116 is a potent neuroprotectant in a rat model of focal cerebral ischemia.
Sauer D; Allegrini PR; Fagg GE
J Neural Transm Suppl; 1994; 43():81-9. PubMed ID: 7884410
[TBL] [Abstract][Full Text] [Related]
9. Competitive NMDA receptor antagonist, CGP 40116, substitutes for the discriminative stimulus effects of ethanol.
Bienkowski P; Stefanski R; Kostowski W
Eur J Pharmacol; 1996 Oct; 314(3):277-80. PubMed ID: 8957246
[TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus effects of the NMDA receptor antagonists MK-801 and CGP 37849 in rats.
Zajaczkowski W; Moryl E; Papp M
Pharmacol Biochem Behav; 1996 Sep; 55(1):163-8. PubMed ID: 8870053
[TBL] [Abstract][Full Text] [Related]
11. N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats.
Tzschentke TM; Schmidt WJ
Neurosci Lett; 1995 Jun; 193(1):37-40. PubMed ID: 7566661
[TBL] [Abstract][Full Text] [Related]
12. An examination of NMDA receptor contribution to conditioned responding evoked by the conditional stimulus effects of nicotine.
Murray JE; Walker AW; Polewan RJ; Bevins RA
Psychopharmacology (Berl); 2011 Jan; 213(1):131-41. PubMed ID: 20859617
[TBL] [Abstract][Full Text] [Related]
13. Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice.
Ribeiro Do Couto B; Aguilar MA; Manzanedo C; Rodríguez-Arias M; Miñarro J
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1035-43. PubMed ID: 15380865
[TBL] [Abstract][Full Text] [Related]
14. The effects of NMDA receptor antagonists at anticonvulsive doses on the performance of rats in the water maze task.
Ylinen A; Pitkänen M; Sirviö J; Hartikainen T; Sivenius J; Koivisto E; Riekkinen PJ
Eur J Pharmacol; 1995 Feb; 274(1-3):159-65. PubMed ID: 7768268
[TBL] [Abstract][Full Text] [Related]
15. Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats.
Bubser M; Keseberg U; Notz PK; Schmidt WJ
Eur J Pharmacol; 1992 Dec; 229(1):75-82. PubMed ID: 1361915
[TBL] [Abstract][Full Text] [Related]
16. The NMDA receptor antagonist MK-801 blocks acquisition and extinction of conditioned hypoalgesic responses in the rat.
Cox J; Westbrook RF
Q J Exp Psychol B; 1994 May; 47(2):187-210. PubMed ID: 8052728
[TBL] [Abstract][Full Text] [Related]
17. The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats.
Hoffman DC
Pharmacol Biochem Behav; 1994 Apr; 47(4):907-12. PubMed ID: 8029261
[TBL] [Abstract][Full Text] [Related]
18. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
Nellgård B; Wieloch T
J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
[TBL] [Abstract][Full Text] [Related]
19. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
Löscher W; Hönack D
J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288
[TBL] [Abstract][Full Text] [Related]
20. NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain.
Nellgård B; Wieloch T
Acta Physiol Scand; 1992 Dec; 146(4):497-503. PubMed ID: 1283483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
